Boston Scientific Profit Margin

The latest profit margin for BSX-PA is 17.47% as of June 2026. That compares with 13.54% in the prior-year period — up 28.9% year over year. That is above the Healthcare sector average of 13.71%. Investors often review this figure alongside Boston Scientific's historical trend and sector peers before judging valuation or financial health.

Over the past year, BSX-PA's profit margin moved from 13.54% to 17.47% — a 28.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Boston Scientific's valuation or profitability profile.

Against Healthcare companies, BSX-PA currently prints 17.47% for profit margin, while the sector average sits near 13.71%. That is roughly 27.4% above the sector mean. Large gaps often invite a closer look at Boston Scientific's growth, margins, and balance sheet.

Profit Margin shows how effectively Boston Scientific converts resources into returns. At 17.47%, BSX-PA may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 13.54% in the prior-year period — up 28.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting BSX-PA's profit margin (17.47%), review year-over-year change from 13.54%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.